Report #2825810

Overview

Sex

Male

Age

46 yrs

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Bexsero to a a high-risk patient who is 46 years old; This non-serious case was reported by a physician via sales rep and described the occurrence of inappropriate age at vaccine administration in a 46-year-old male patient who received Men B NVS (Bexsero) for prophylaxis. Concomitant products included Meningococcal vaccine A/C/Y/W conj (CRM197) (Menveo). On an unknown date, the patient received Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: Bexsero to a a high-risk patient who is 46 years old). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 14-JAN-2025 The physician reported that healthcare professional gave Bexsero to a a high-risk patient who was 46 years old which led to inappropriate age at vaccine administration.

Other medications

MENVEO